Home » Stocks » ORGS

Orgenesis Inc. (ORGS)

Stock Price: $4.95 USD 0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 119.57M
Revenue (ttm) 14.43M
Net Income (ttm) -58.78M
Shares Out 24.16M
EPS (ttm) 2.35
PE Ratio 2.11
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $4.95
Previous Close $4.95
Change ($) 0.00
Change (%) 0.00%
Day's Open 4.89
Day's Range 4.86 - 5.00
Day's Volume 13,055
52-Week Range 2.60 - 7.84

More Stats

Market Cap 119.57M
Enterprise Value 42.30M
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 24.16M
Float n/a
EPS (basic) 2.17
EPS (diluted) 2.35
FCF / Share -1.94
Dividend n/a
Dividend Yield n/a
Earnings Yield 47.47%
FCF Yield n/a
Payout Ratio n/a
Shares Short 381,977
Short Ratio 11.36
Short % of Float n/a
Beta 1.37
PE Ratio 2.11
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.28
PB Ratio 1.38
Revenue 14.43M
Operating Income -49.64M
Net Income -58.78M
Free Cash Flow -42.82M
Net Cash 77.27M
Net Cash / Share 3.20
Gross Margin 41.93%
Operating Margin -343.91%
Profit Margin -407.30%
FCF Margin -296.69%
ROA -15.09%
ROE n/a
ROIC -323.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$9.00*
Low
9.00
Current: $4.95
High
9.00
Target: 9.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue33.2618.6610.096.402.97-----
Revenue Growth78.27%84.9%57.71%115.1%------
Gross Profit15.027.833.28-1.26-0.91-----
Operating Income-24.83-16.85-10.02-11.28-7.21-4.58-5.46-4.99-0.07-0.04
Net Income-24.12-18.29-12.37-11.11-4.46-5.50-5.54-5.00-0.07-0.04
Shares Outstanding15.9113.379.688.524.654.514.214.526.716.71
Earnings Per Share1.771.43-1.31-1.30-1.32-1.32-1.32-1.08--
EPS Growth23.78%---------
Operating Cash Flow-13.22-15.68-3.83-3.78-2.71-1.43-1.99-1.05--0.01
Capital Expenditures-12.05-5.56-0.98-1.43-0.98-0.01-0.01-0.01--
Free Cash Flow-25.27-21.24-4.81-5.21-3.69-1.43-2.00-1.06--0.01
Cash & Equivalents0.57-3.520.894.171.310.060.010.000.00
Total Debt13.76-7.699.8510.282.450.26---
Net Cash / Debt-13.19--4.17-8.96-6.11-1.14-0.200.010.000.00
Assets92.50-39.8733.4938.752.250.110.05--
Liabilities55.46-22.1420.9923.735.232.150.330.090.01
Book Value5.48-14.1212.50-6.44-2.98-2.03-0.28-0.08-0.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Orgenesis Inc.
Country United States
Employees 309
CEO Vered Caplan

Stock Information

Ticker Symbol ORGS
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ORGS

Description

Orgenesis offers biotechnology solutions focusing on cell and gene therapies (CGTs). The company's Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on identification of new therapies and leverages its POCare platform to provide a pathway for these therapies to treat patients. Additionally, the company's Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies. Orgenesis Inc. was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. The company was founded in 2008 and is based in Germantown, Maryland.